Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Evozyne Announces $81M Series B

2023-09-29
CHICAGO, IL, Evozyne announced $81 Million in Series B funding led by Fidelity Management & Research Company and OrbiMed.
Evozyne announced $81 Million in Series B funding led by Fidelity Management & Research Company and OrbiMed with participation from NVentures, NVIDIA's venture capital arm. Previous investors Paragon Biosciences and Valor Equity Partners expanded their support in the round.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors